|
2022-08-12 |
2022-08-11 |
B
Compra
|
Gran accionista
|
38 259
+33.7%
448,61
3.612.337 US$
|
38 259
+33.7%
|
448,61
|
3.612.337 US$
|
|
|
2022-08-11 |
2022-08-10 |
B
Compra
|
Gran accionista
|
84 320
-1.0%
123,99
1.937.212 US$
|
84 320
-1.0%
|
123,99
|
1.937.212 US$
|
|
|
2022-05-20 |
2022-05-18 |
B
Compra
|
Gran accionista
|
99 230
-37.3%
185,25
1.626.849 US$
|
99 230
-37.3%
|
185,25
|
1.626.849 US$
|
|
|
2022-01-07 |
2022-01-06 |
B
Compra
|
Gran accionista
|
300 000
+3.8%
6,31
1.894.410 US$
|
300 000
+3.8%
|
6,31
|
1.894.410 US$
|
|
|
2022-01-07 |
2022-01-05 |
B
Compra
|
Gran accionista
|
250 000
+3.2%
6,30
1.574.650 US$
|
250 000
+3.2%
|
6,30
|
1.574.650 US$
|
|
|
2021-12-16 |
2021-12-16 |
B
Compra
|
Gran accionista
|
146 685
+2.2%
7,07
1.037.752 US$
|
146 685
+2.2%
|
7,07
|
1.037.752 US$
|
|
|
2021-12-15 |
2021-12-15 |
B
Compra
|
Gran accionista
|
180 744
+2.7%
6,77
1.223.637 US$
|
180 744
+2.7%
|
6,77
|
1.223.637 US$
|
|
|
2021-12-15 |
2021-12-14 |
B
Compra
|
Gran accionista
|
94 103
+1.4%
6,81
640.936 US$
|
94 103
+1.4%
|
6,81
|
640.936 US$
|
|
|
2021-12-15 |
2021-12-13 |
B
Compra
|
Gran accionista
|
187 391
+3.0%
7,08
1.326.803 US$
|
187 391
+3.0%
|
7,08
|
1.326.803 US$
|
|
|
2021-12-10 |
2021-12-10 |
B
Compra
|
Gran accionista
|
768 171
+13.8%
7,18
5.511.627 US$
|
768 171
+13.8%
|
7,18
|
5.511.627 US$
|
|
|
2021-12-10 |
2021-12-09 |
B
Compra
|
Gran accionista
|
264 644
+5.0%
7,58
2.007.087 US$
|
264 644
+5.0%
|
7,58
|
2.007.087 US$
|
|
|
2021-12-10 |
2021-12-08 |
B
Compra
|
Gran accionista
|
560 691
+11.8%
8,02
4.497.078 US$
|
560 691
+11.8%
|
8,02
|
4.497.078 US$
|
|
|
2021-10-01 |
2021-09-29 |
B
Compra
|
Gran accionista
|
100 000
+1.3%
12,95
1.294.500 US$
|
100 000
+1.3%
|
12,95
|
1.294.500 US$
|
|
|
2021-03-09 |
2021-03-05 |
Por favor
Venta prevista
|
Principal Finance Accounting
Oficial
|
370
-5.2%
20,88
7.726 US$
|
370
-5.2%
|
20,88
|
7.726 US$
|
|
|
2021-02-26 |
2021-02-25 |
S
Venta
|
Chief Commercial Officer
Oficial
|
1 322
-10.1%
18,93
25.025 US$
|
1 322
-10.1%
|
18,93
|
25.025 US$
|
|
|
2020-11-09 |
2020-11-05 |
B
Compra
|
Gran accionista
|
100 000
+1.4%
14,26
1.426.230 US$
|
100 000
+1.4%
|
14,26
|
1.426.230 US$
|
|
|
2020-09-16 |
2020-09-14 |
B
Compra
|
Gran accionista
|
200 000
+2.8%
11,69
2.338.680 US$
|
200 000
+2.8%
|
11,69
|
2.338.680 US$
|
|
|
2020-09-14 |
2020-09-11 |
B
Compra
|
Gran accionista
|
199 029
+2.9%
11,33
2.255.118 US$
|
199 029
+2.9%
|
11,33
|
2.255.118 US$
|
|
|
2020-07-09 |
2020-07-08 |
B
Compra
|
Gran accionista
|
25 000
+0.4%
13,21
330.178 US$
|
25 000
+0.4%
|
13,21
|
330.178 US$
|
|
|
2020-05-04 |
2020-04-30 |
B
Compra
|
Gran accionista
|
50 000
+0.7%
15,75
787.555 US$
|
50 000
+0.7%
|
15,75
|
787.555 US$
|
|
|
2020-02-28 |
2020-02-26 |
Por favor
Venta prevista
|
Consejero no ejecutivo
|
2 750
-20.5%
17,95
49.362 US$
|
2 750
-20.5%
|
17,95
|
49.362 US$
|
|
|
2020-02-28 |
2020-02-26 |
S
Venta
|
Chief Financial Officer
Oficial
|
1 292
-2.7%
17,93
23.169 US$
|
1 292
-2.7%
|
17,93
|
23.169 US$
|
|
|
2020-02-28 |
2020-02-26 |
Por favor
Venta prevista
|
Consejero no ejecutivo
|
1 925
-13.6%
17,95
34.554 US$
|
1 925
-13.6%
|
17,95
|
34.554 US$
|
|
|
2020-02-28 |
2020-02-26 |
S
Venta
|
Chief Medical Officer
Oficial
|
1 256
-3.6%
17,93
22.524 US$
|
1 256
-3.6%
|
17,93
|
22.524 US$
|
|
|
2020-02-28 |
2020-02-26 |
Por favor
Venta prevista
|
Consejero no ejecutivo
|
1 815
-12.8%
17,95
32.579 US$
|
1 815
-12.8%
|
17,95
|
32.579 US$
|
|
|
2020-02-28 |
2020-02-26 |
S
Venta
|
Sr. VP of Sales and Marketing
Oficial
|
889
-3.6%
17,93
15.942 US$
|
889
-3.6%
|
17,93
|
15.942 US$
|
|
|
2019-11-08 |
2019-11-06 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
100 000
+1.5%
23,00
2.300.300 US$
|
100 000
+1.5%
|
23,00
|
2.300.300 US$
|
|
|
2019-07-03 |
2019-07-01 |
Por favor
Venta prevista
|
|
1 584
-15.4%
24,60
38.966 US$
|
1 584
-15.4%
|
24,60
|
38.966 US$
|
|
|
2019-06-11 |
2019-06-07 |
B
Compra
|
Sr. VP of Sales and Marketing
|
2 500
+50.0%
21,81
54.536 US$
|
2 500
+50.0%
|
21,81
|
54.536 US$
|
|
|
2019-05-13 |
2019-05-10 |
B
Compra
|
Sr. VP of Sales and Marketing
|
2 000
+66.7%
21,43
42.860 US$
|
2 000
+66.7%
|
21,43
|
42.860 US$
|
|
|
2019-04-18 |
2019-04-16 |
Por favor
Venta prevista
|
|
1 680
-16.3%
22,22
37.330 US$
|
1 680
-16.3%
|
22,22
|
37.330 US$
|
|
|
2019-04-18 |
2019-04-16 |
Por favor
Venta prevista
|
|
4 800
-46.6%
22,32
107.136 US$
|
4 800
-46.6%
|
22,32
|
107.136 US$
|
|
|
2019-04-18 |
2019-04-16 |
Por favor
Venta prevista
|
|
2 400
-23.3%
22,22
53.328 US$
|
2 400
-23.3%
|
22,22
|
53.328 US$
|
|
|
2019-04-12 |
2019-04-11 |
Por favor
Venta prevista
|
|
4 800
-46.6%
22,15
106.320 US$
|
4 800
-46.6%
|
22,15
|
106.320 US$
|
|
|
2019-03-06 |
2019-03-05 |
B
Compra
|
|
12 800
+inf%
19,23
246.190 US$
|
12 800
+inf%
|
19,23
|
246.190 US$
|
|
|
2018-12-21 |
2018-12-20 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
60 000
+0.9%
14,48
868.782 US$
|
60 000
+0.9%
|
14,48
|
868.782 US$
|
|
|
2018-12-18 |
2018-12-17 |
B
Compra
|
Kelly Joseph Francis
Sr. VP of Sales and Marketing
Oficial
|
3 000
+inf%
15,71
47.130 US$
|
3 000
+inf%
|
15,71
|
47.130 US$
|
|
|
2018-12-17 |
2018-12-14 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
60 000
+0.9%
15,64
938.256 US$
|
60 000
+0.9%
|
15,64
|
938.256 US$
|
|
|
2018-08-22 |
2018-08-20 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
60 000
+0.9%
19,65
1.178.808 US$
|
60 000
+0.9%
|
19,65
|
1.178.808 US$
|
|
|
2018-08-16 |
2018-08-15 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
69 363
+1.1%
20,78
1.441.530 US$
|
69 363
+1.1%
|
20,78
|
1.441.530 US$
|
|
|
2018-08-16 |
2018-08-14 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
100 000
+1.6%
20,87
2.086.880 US$
|
100 000
+1.6%
|
20,87
|
2.086.880 US$
|
|
|
2018-08-10 |
2018-08-08 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
60 000
+1.0%
22,73
1.363.884 US$
|
60 000
+1.0%
|
22,73
|
1.363.884 US$
|
|
|
2018-07-30 |
2018-07-27 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
50 000
+0.8%
24,81
1.240.605 US$
|
50 000
+0.8%
|
24,81
|
1.240.605 US$
|
|
|
2018-07-26 |
2018-07-25 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
50 000
+0.8%
27,28
1.363.805 US$
|
50 000
+0.8%
|
27,28
|
1.363.805 US$
|
|
|
2018-06-13 |
2018-06-11 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
50 000
+0.8%
27,36
1.367.835 US$
|
50 000
+0.8%
|
27,36
|
1.367.835 US$
|
|
|
2018-05-24 |
2018-05-23 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
40 000
+0.7%
28,91
1.156.320 US$
|
40 000
+0.7%
|
28,91
|
1.156.320 US$
|
|
|
2018-05-23 |
2018-05-21 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
60 000
+1.0%
29,27
1.756.380 US$
|
60 000
+1.0%
|
29,27
|
1.756.380 US$
|
|
|
2018-04-23 |
2018-04-19 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
40 000
+0.7%
33,80
1.351.936 US$
|
40 000
+0.7%
|
33,80
|
1.351.936 US$
|
|
|
2018-04-09 |
2018-04-05 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
50 000
+0.9%
36,58
1.828.845 US$
|
50 000
+0.9%
|
36,58
|
1.828.845 US$
|
|
|
2018-03-06 |
2018-03-02 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
80 000
+1.4%
32,52
2.601.448 US$
|
80 000
+1.4%
|
32,52
|
2.601.448 US$
|
|
|
2018-02-12 |
2018-02-09 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
75 000
+1.3%
34,38
2.578.762 US$
|
75 000
+1.3%
|
34,38
|
2.578.762 US$
|
|
|
2017-11-16 |
2017-11-14 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
50 000
+0.9%
26,25
1.312.390 US$
|
50 000
+0.9%
|
26,25
|
1.312.390 US$
|
|
|
2017-11-13 |
2017-11-10 |
B
Compra
|
Hatzis-Schoch Brent
Sr. VP, General Counsel
|
1 778
+355.6%
28,09
49.943 US$
|
1 778
+355.6%
|
28,09
|
49.943 US$
|
|
|
2017-11-07 |
2017-11-07 |
B
Compra
|
Hoiland Jesper
President and CEO
Consejero ejecutivo
|
6 800
+111.5%
29,04
197.450 US$
|
6 800
+111.5%
|
29,04
|
197.450 US$
|
|
|
2017-11-07 |
2017-11-03 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
50 000
+0.9%
29,15
1.457.575 US$
|
50 000
+0.9%
|
29,15
|
1.457.575 US$
|
|
|
2017-10-27 |
2017-10-26 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
50 000
+0.9%
30,95
1.547.550 US$
|
50 000
+0.9%
|
30,95
|
1.547.550 US$
|
|
|
2017-10-26 |
2017-10-25 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
50 000
+0.9%
32,85
1.642.415 US$
|
50 000
+0.9%
|
32,85
|
1.642.415 US$
|
|
|
2017-09-15 |
2017-09-15 |
B
Compra
|
Hoiland Jesper
President and CEO
Consejero ejecutivo
|
6 100
+inf%
32,72
199.608 US$
|
6 100
+inf%
|
32,72
|
199.608 US$
|
|
|
2017-09-15 |
2017-09-14 |
B
Compra
|
Carmona Jose
Chief Financial Officer
|
3 000
+inf%
32,83
98.503 US$
|
3 000
+inf%
|
32,83
|
98.503 US$
|
|
|
2017-09-15 |
2017-09-14 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
50 000
+0.9%
32,94
1.647.225 US$
|
50 000
+0.9%
|
32,94
|
1.647.225 US$
|
|
|
2017-09-15 |
2017-09-13 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
100 000
+1.9%
33,71
3.370.750 US$
|
100 000
+1.9%
|
33,71
|
3.370.750 US$
|
|
|
2017-09-13 |
2017-09-12 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
50 000
+0.9%
35,42
1.770.820 US$
|
50 000
+0.9%
|
35,42
|
1.770.820 US$
|
|
|
2017-09-07 |
2017-09-05 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
50 000
+1.0%
36,75
1.837.625 US$
|
50 000
+1.0%
|
36,75
|
1.837.625 US$
|
|
|
2017-08-18 |
2017-08-16 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
60 000
+1.2%
35,98
2.158.536 US$
|
60 000
+1.2%
|
35,98
|
2.158.536 US$
|
|
|
2017-08-11 |
2017-08-10 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
75 000
+1.5%
34,26
2.569.500 US$
|
75 000
+1.5%
|
34,26
|
2.569.500 US$
|
|
|
2017-08-11 |
2017-08-09 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
75 000
+1.5%
35,67
2.675.528 US$
|
75 000
+1.5%
|
35,67
|
2.675.528 US$
|
|
|
2017-05-31 |
2017-05-30 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
40 000
+0.8%
34,21
1.368.348 US$
|
40 000
+0.8%
|
34,21
|
1.368.348 US$
|
|
|
2017-05-30 |
2017-05-25 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
40 000
+0.8%
36,25
1.450.020 US$
|
40 000
+0.8%
|
36,25
|
1.450.020 US$
|
|
|
2017-05-22 |
2017-05-18 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
50 000
+1.0%
34,41
1.720.345 US$
|
50 000
+1.0%
|
34,41
|
1.720.345 US$
|
|
|
2017-05-18 |
2017-05-17 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
18 000
+0.4%
32,98
593.662 US$
|
18 000
+0.4%
|
32,98
|
593.662 US$
|
|
|
2017-05-18 |
2017-05-16 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
17 000
+0.3%
33,93
576.725 US$
|
17 000
+0.3%
|
33,93
|
576.725 US$
|
|
|
2017-05-16 |
2017-05-12 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
15 000
+0.3%
34,00
509.996 US$
|
15 000
+0.3%
|
34,00
|
509.996 US$
|
|
|
2017-05-11 |
2017-05-09 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
50 000
+1.0%
35,93
1.796.480 US$
|
50 000
+1.0%
|
35,93
|
1.796.480 US$
|
|
|
2017-05-09 |
2017-05-08 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
22 800
+0.5%
35,60
811.630 US$
|
22 800
+0.5%
|
35,60
|
811.630 US$
|
|
|
2017-05-09 |
2017-05-05 |
B
Compra
|
BIOTECH GROWTH N V
Gran accionista
|
20 600
+0.4%
35,55
732.283 US$
|
20 600
+0.4%
|
35,55
|
732.283 US$
|
|